Long‐term course and mutational spectrum of spatacsin‐linked spastic paraplegia
Authors:
- Beate WinnerBWBeate Winner
- Anna EngelAEAnna Engel
- Daniela LenzDLDaniela Lenz
- Andrea SeibelASAndrea Seibel
- Sonja PloetzSPSonja Ploetz
- 7 December 2007
- journal article
- case report
- Published by Wiley in Annals of Neurology
- Vol. 62 (6) , 656-665
Abstract
Objective: Hereditary spastic paraplegias (HSPs) comprise a heterogeneous group of neurodegenerative disorders resulting in progressive spasticity of the lower limbs. One form of autosomal recessive hereditary spastic paraplegia (ARHSP) with thin corpus callosum (TCC) was linked to chromosomal region 15q13‐21 (SPG11) and associated with mutations in the spatacsin gene. We assessed the long‐term course and the mutational spectrum of spatacsin‐associated ARHSP with TCC.Methods: Neurological examination, cerebral magnetic resonance imaging (MRI), 18fluorodeoxyglucose positron emission tomography (PET), nerve biopsy, linkage and mutation analysis are presented.Results: Spastic paraplegia in patients with spatacsin mutations (n = 20) developed during the second decade of life. The Spastic Paraplegia Rating Scale (SPRS) showed severely compromised walking between the second and third decades of life (mean SPRS score, >30). Impaired cognitive function was associated with severe atrophy of the frontoparietal cortex, TCC, and bilateral periventricular white matter lesions. Progressive cortical and thalamic hypometabolism in the 18fluorodeoxyglucose PET was observed. Sural nerve biopsy showed a loss of unmyelinated nerve fibers and accumulation of intraaxonal pleomorphic membranous material. Mutational analysis of spatacsin demonstrated six novel and one previously reported frameshift mutation and two novel nonsense mutations. Furthermore, we report the first two splice mutations to be associated with SPG11.Interpretation: We demonstrate that not only frameshift and nonsense mutations but also splice mutations result in SPG11. Mutations are distributed throughout the spatacsin gene and emerge as major cause for ARHSP with TCC associated with severe motor and cognitive impairment. The clinical phenotype and the ultrastructural analysis suggest a disturbed axonal transport of long projecting neurons. Ann Neurol 2007Keywords
This publication has 33 references indexed in Scilit:
- Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosumNature Genetics, 2007
- New developments in the InterPro databaseNucleic Acids Research, 2007
- Ensembl 2007Nucleic Acids Research, 2006
- Thin corpus callosum and amyotrophy in spastic paraplegia—Case report and review of literatureClinical Neurology and Neurosurgery, 2006
- Further Clinical and Genetic Characterization of SPG11: Hereditary Spastic Paraplegia with Thin Corpus CallosumNeuropediatrics, 2006
- Der interhemispherielle Transfer und seine Relevanz in der Neurologie und PsychiatrieFortschritte der Neurologie · Psychiatrie, 2003
- The K–Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosumNature Genetics, 2002
- Neuroradiological findings in hereditary spastic paraplegia with a thin corpus callosumActa Neurologica Scandinavica, 2001
- Oral glucose lactate stimulation test in mitochondrial diseasesPediatric Neurology, 1992
- β‐Mannosidase deficiency: Heterogeneous manifestation in the first female patient and her brotherJournal of Inherited Metabolic Disease, 1990